Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapy
Authors:
- Linda DanskyLDLinda Dansky
- Eva AndermannEAEva Andermann
- Allan SherwinASAllan Sherwin
- Frederick AndermannFAFrederick Andermann
- 1 November 1992
- journal article
- Published by Elsevier in Brain and Development
- Vol. 14 (6) , 371-380
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Facial clefts and congenital heart defects in children of parents with epilepsy: genetic and environmental etiologic factorsActa Neurologica Scandinavica, 1989
- The course of epilepsy during pregnancy: a study of 78 casesActa Neurologica Scandinavica, 1988
- Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk FactorsEpilepsia, 1988
- Teratogenicity of anticonvulsant drugs. IV: The association of clefting and epilepsyAmerican Journal of Medical Genetics, 1984
- Chronic toxicity in epileptic patients receiving single-drug treatmentBMJ, 1982
- Embryotoxicity of the folate antagonist methotrexate in rats and rabbitsTeratology, 1977
- ANTICONVULSANTS AND PARENTAL EPILEPSY IN THE DEVELOPMENT OF BIRTH DEFECTSThe Lancet, 1976
- Epilepsy and Pregnancy: A Study of 153 Pregnancies in 59 PatientsEpilepsia, 1975
- CONGENITAL MALFORMATIONS AND ANTICONVULSANT DRUGSThe Lancet, 1973
- Folate status and requirement in pregnancy.BMJ, 1968